Development of laser-induced choroidal neovascularization in rats after retinal damage by sodium iodate injection

Ophthalmic Research

Volumn 42, Issue 4, 2009, Pages 205-212

  García Layana, Alfredo ^a   Vásquez, Gustavo ^a   Salinas Alamán, Angel ^a   Moreno Montañés, Javier ^a   Recalde, Sergio ^a   Fernández Robredo, Patricia ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Choroidal neovascularization; Diode laser; Retinal damage; Sodium iodate

Indexed keywords

SODIUM IODATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIODE LASER; EYE BURN; FLUORESCENCE ANGIOGRAPHY; INCIDENCE; LASER COAGULATION; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RAT; RETINA HEMORRHAGE; RETINA INJURY; SUBRETINAL NEOVASCULARIZATION;

ANIMALS; CHOROIDAL NEOVASCULARIZATION; FLUORESCEIN ANGIOGRAPHY; INJECTIONS, INTRAVENOUS; IODATES; LASER COAGULATION; RATS; RATS, LONG-EVANS; RETINA; RETINAL PIGMENT EPITHELIUM;

EID: 68349083398     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000232946     Document Type: Article

References (36)

1. Lim JI: Iatrogenic choroidal neovascularisation. Surv Ophthalmol 1999; 44: 95-111.
2. Klein R, Peto T, Bird A, Vannewkirk MR: The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004; 137: 486-495.
3. Amin R, Puklin JE, Frank RN: Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest Ophthalmol Vis Sci 1994; 35: 3178-3188.
4. Gragoudas ES, Adamis AP, Cunningham ET Jr, et al: Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004; 351: 2805-2816.
5. Sakurai E, Anand A, Ambati BK, et al: Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2003; 44: 3578-3585. (Pubitemid 36909798)
6. Espinosa-Heidmann DG, Suner IJ, Hernandez EP, Monroy D, et al: Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2003; 44: 3586-3592.
7. Lopez PF, Sippy BD, Lambert HM, et al: Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1996; 37: 855-868.
8. Grossniklaus HE, Ling JX, Wallace TM, et al: Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis 2002; 8: 119-126.
9. Marneros AG, Fan J, Yokoyama Y, et al: Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol 2005; 167: 1451-1459.
10. Nilsson SE, Knave B, Persson HE: Changes in ultrastructure and function of the sheep pigment epithelium and retina induced by SI. II. Early effects. Acta Ophthalmol (Copenh) 1977; 55: 1007-1026. (Pubitemid 8246485)
11. Korte GE, Reppucci V, Henkind P: RPE destruction causes choriocapillary atrophy. Invest Ophthalmol Vis Sci 1984; 25: 1135-1145.
12. Ishida K, Yoshimura N, Mandai M, Honda Y: Inhibitory effect of TNP-470 on experimental choroidal neovascularization in a rat model. Invest Ophthalmol Vis Sci 1999; 40: 1512-1519. (Pubitemid 29252343)
13. Apte RS, Barreiro RA, Duh E, et al: Stimulation of neovascularization by the anti-angiogenic factor PEDF. Invest Ophthalmol Vis Sci 2004; 45: 4491-4497.
14. Barbaztto I, Burdan A, Bressler NM, Bressler SB, Haynes L, Kapetanios AD, Lukas J, Olsen K, Potter M, Reaves A, Rosenfeld P, Schachat AP, Strong HA, Wenkstern A: Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment-TAP and VIP report No. 2. Arch Ophthalmol 2003; 121: 1253-1268.
15. Jo N, Ju M, Nishijima K, Robinson GS, et al: Inhibitory effect of an antibody to cryptic collagen type IV epitopes on choroidal neovascularization. Mol Vis 2006; 12: 1243-1249.
16. Kiilgaard JF, Andersen MV, Wiencke AK, et al: A new animal model of choroidal neovascularization. Acta Ophthalmol Scand 2005; 83: 697-704.
17. Vasquez Lopez G, Jaurrieta Alegria M, et al: Experimental model of subretinal neovascularization. Arch Soc Esp Oftalmol 2000; 75: 675-680.
18. El Bradey M, Cheng L, Bartsch, et al: Preventive versus treatment effect of AG3340, a potent matrix metalloproteinase inhibitor in a rat model of choroidal neovascularization. J Ocul Pharmacol Ther 2004; 20: 217-236.
19. Jo N, Mailhos C, Ju M, et al: Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization. Am J Pathol 2006; 168: 2036-2053.
20. Takeuchi A, Kricorian G, Yao XY, et al: The rate and source of albumin entry into salinefilled experimental retinal detachments. Invest Ophthalmol Vis Sci 1994; 35: 3792-3798.
21. Ringvold A, Olsen EG, Flage T: Transient breakdown of the retinal pigment epithelium diffusion barrier after SI: A fluorescein angiographic and morphological study in the rabbit. Exp Eye Res 1981; 33: 361-369.
22. Konda BR, Pararajasegaram G, Wu GS, et al: Role of retinal pigment epithelium in the development of experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 1994; 35: 40-47.
23. Tsai DC, Charng MJ, Lee FL, et al: Different plasma levels of vascular endothelial growth factor and nitric oxide between patients with choroidal and retinal neovascularization. Ophthalmologica 2006; 220: 246-251.
24. Kiuchi K, Yoshizawa K, Shikata N, et al: Morphologic characteristics of retinal degeneration induced by SI in mice. Curr Eye Res 2002; 25: 373-379.
25. Li Y, Reca RG, Atmaca-Sonmez P, et al: Retinal pigment epithelium damage enhances expression of chemoattractants and migration of bone marrow-derived stem cells. Invest Ophthalmol Vis Sci 2006; 47: 1646-1652.
26. Chan-Ling T, Baxter L, Afzal A, et al: Hematopoietic stem cells provide repair functions after laser-induced Bruch's membrane rupture model of choroidal neovascularization. Am J Pathol 2006; 168: 1031-1044.
27. Birrer L: Histochemistry of SI and sodium iodoacetate retinopathy. Ophthalmologica 1970; 160: 176-194.
28. Nishimura T, Zhu ZR, Ryan SJ: Effects of sodium iodate on experimental subretinal neovascularization in the primate. Ophthalmologica 1990; 200: 28-38.
29. Tong JP, Yao YF: Contribution of VEGF and PEDF to choroidal angiogenesis: A need for balanced expressions. Clin Biochem 2006; 39: 267-276.
30. Wada M, Ogata N, Otsuji T, Uyama M: Expression of vascular endothelial growth factor and its receptor (KDR/flk-1) mRNA in experimental choroidal neovascularization. Curr Eye Res 1999; 18: 203-213. (Pubitemid 29213835)
31. Ishibashi T, Hata Y, Yoshikawa H, et al: Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefe's Arch Clin Exp Ophthalmol 1997; 235: 159-167.
32. Yi X, Takahashi K, Ogata N, et al: Immunohistochemical proof of origin of macrophages in laser photocoagulation lesion in the retina. Jpn J Ophthalmol 1996; 40: 192-201. (Pubitemid 26290251)
33. Oh H, Takagi H, Takagi C, et al: The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1999; 40: 1891-1898.
34. Saxe SJ, Grossniklaus HE, Lopez PF, et al: Ultrastructural features of surgically excised subretinal neovascular membranes in the ocular histoplasmosis syndrome. Arch Ophthalmol 1993; 111: 88-95.
35. Grossniklaus HE, Green WR: Histopathologic and ultrastructural findings of surgically excised choroidal neovascularization. Submacular Surgery Trials Research Group. Arch Ophthalmol 1998; 116: 745-749.
36. Tsutsumi C, Sonoda KH, Egashira K, et al: The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. J Leukoc Biol 2003; 74: 25-32.